Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD

Respiratory Medicine

Volumn 101, Issue 8, 2007, Pages 1670-1676

  Tkacova, Ruzena ^a   Kluchova, Zuzana ^a   Joppa, Pavol ^a   Petrasova, Darina ^a   Molcanyiova, Angela ^b  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b LABMED   (Slovakia)

Author keywords

C reactive protein; COPD; Glutathione peroxidase; Oxidative stress; Systemic inflammation

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; GLUTATHIONE PEROXIDASE; HYDROCORTISONE; INTERLEUKIN 6; IPRATROPIUM BROMIDE; LONG ACTING DRUG; OXYGEN; SALBUTAMOL; SHORT ACTING DRUG; THEOPHYLLINE DERIVATIVE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; ENZYME ACTIVITY; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; OXIDATIVE STRESS; OXYGEN THERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 34250622531     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.03.005     Document Type: Article

References (33)

1. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2 (2005) 50-60
2. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol 36 (2003) 95-109
3. Kluchova Z, Petrasova D, Joppa P, Dorkova Z, Tkacova R. The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res [Epub ahead of print].
4. Ochs-Balcom H.M., Grant B.J., Muti P., et al. Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD. Eur J Clin Nutr 60 (2006) 991-999
5. Hogg J.C., Chu F., Utokaparch S., et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 2645-2653
6. Gan W.Q., Man S.F.P., Senthilselvan A., and Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and meta-analysis. Thorax 59 (2004) 574-580
7. de Torres J.P., Cordoba-Lanus E., Lopez-Aguillar C., et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 27 (2006) 902-907
8. Broekhuizen R., Wouters E.F., Creutzberg E.C., and Schols A.M. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61 (2006) 17-22
9. Man S.F., Connett J.E., Anthonisen N.R., Wise R.A., Tashkin D.P., and Sin D.D. C-reactive protein and mortality in mild to moderate obstructive pulmonary disease. Thorax 61 (2006) 849-853
10. Do Lee C., Folsom A.R., Nieto F.J., Chambless L.E., Shahar E., and Wolfe D.A. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and white men and women. Am J Epidemiol 154 (2001) 758-764
11. Horne B.D., Anderson J.L., John J.M., et al. Which white blood cell subtypes predict increased cardiovascular risk?. Am J Cardiol 45 (2005) 1638-1643
12. Zhang R., Brennan M.L., Fu X., et al. Association between myeloperoxidase levels and risk of coronary artery disease. J Am Med Assoc 286 (2001) 2136-2142
13. Blankenberg S., Rupprecht H.J., Bickel C., et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349 (2003) 1605-1613
14. Abramson J.L., Hooper W.C., Jones D.P., et al. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis 178 (2005) 115-121
15. Sin D.D., and Man S.F.P. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases?. Circulation 107 (2003) 1514-1519
16. Rahman I. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys 43 (2005) 167-188
17. Beeh K.M., Beier J., Koppenhoefer N., and Buhl R. Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD. Chest 126 (2004) 1116-1122
18. Kostikas K., Papatheodorou G., Psathakis K., Panagou P., and Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 124 (2003) 1373-1380
19. Gerritsen W.B.M., Asin J., Zanen P., van den Bosch J.M.M., and Haas F.J.L.M. Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir Med 99 (2005) 84-90
20. Sadowska A.M., van Overveld F.J., Gorecka D., et al. The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant. Respir Med 99 (2005) 241-249
21. Celli B.R., and MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
22. Burge S., and Wedzicha J.A. COPD exacerbations: definitions and classifications. Eur Respir J 21 Suppl. 41 (2003) 46s-53s
23. Anthonisen N.R., Manfreda J., Warren C.P., et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106 (1987) 196-204
24. Rodriguez-Roisin R. Towards a consensus definition for COPD exacerbations. Chest 117 (2000) 398S-401S
25. Perera W.R., Hurst J.R., Wilkinson T.M., et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 29 (2007) 527-534
26. Hurst J.R., Perera W.R., Wilkinson T.M.A., Donaldson G.C., and Wedzicha J.A. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173 (2006) 71-78
27. Miller M.R., Hankinson J., Brusasco V., et al. Standardisation of spirometry. Eur Respir J 26 (2005) 319-338
28. Antczak A., Kharitonov S.A., Montuschi P., Gorski P., and Barnes P.J. Inflammatory response to sputum induction measured by exhaled markers. Respiration 72 (2005) 594-599
29. Keatings V.M., and Barnes P.J. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 155 (1997) 449-453
30. Baraldo S., Turato G., Badin C., et al. Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax 59 (2004) 308-312
31. Santus P., Sola A., Carlucci P., et al. Lipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 (2005) 838-843
32. Sin D.D., and Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular events? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107 (2003) 1514-1519
33. Pinto-Plata V., Toso J., Lee K., et al. Use of proteomic patterns of serum biomarkers in patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 3 (2006) 465-466